Oncternal Therapeutics, Inc. ONCT
0.53 0.00 0.00%
At close · Dec 2
52-week range unavailable
- Open
- 0.70
- Prev close
- 0.5266
- Mkt cap
- 1.56M
- Vol
- 644.13K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.5266
- High
- 0.70
- Forward P/E
- -0.05
- Beta
- 0.00
- Short ratio
- 0.09
- Inst. own
- 12.07%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 6, 2024
- 50-d avg
- 1.06
- 200-d avg
- 5.13
- 1y target
- 2.00
MAX chart
Chart tools
Chart is warming up
The all-time price history for ONCT has not been loaded yet. Try again in a moment.
Altman Z-Score
-26.66 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
P/E -0.8×
P/S 40.1×
P/B 1.0×
P/FCF -1.0×
EV/EBITDA 11.2×
EV/Sales 32.0×
FCF Yield -102.1%
Gross Margin -3690.2%
Operating Margin -5313.9%
Net Margin -5029.2%
ROE -131.4%
ROIC -131.6%
ROA -107.5%
Revenue -47.3%
Operating Income 7.2%
EPS (diluted) 18.6%
Free Cash Flow 12.4%
Current Ratio 6.9×
Quick Ratio 6.9×
Debt / Equity 0.0×
Net Debt / EBITDA -2.9×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2023-12-31